CIK 0002019410 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in TX · fiscal year ends 12/31
| FY2025 | |
|---|---|
| Revenue (USD) | 812.0 M |
| Net income (USD) | -68.1 M |
| Diluted EPS (USD/shares) | -3.22 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-23 | 4 | FORM 4 | 2026-09-22 |
| 2026-09-22 | 144 | 144 | |
| 2026-09-17 | 4 | FORM 4 | 2026-09-17 |
| 2026-09-17 | 144 | 144 | |
| 2026-09-14 | 8-K | 8-K items 7.01 | 2026-09-14 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-03 |
| 2026-09-04 | 144 | 144 | |
| 2026-09-03 | 144 | 144 | |
| 2026-08-24 | 144 | 144 | |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | 144 | 144 | |
| 2026-08-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-08-03 | 144 | 144 | |
| 2026-07-13 | 4 | FORM 4 | 2026-05-15 |
| 2026-06-16 | CERT | NYSE TEXAS CERTIFICATION |
Forms on file (last 1,000): 4 50, 3 17, 8-K 11, 144 8, SCHEDULE 13G/A 6, SCHEDULE 13G 5, DRS/A 5, 10-Q 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CAI (0.002 USD), /gw/filings/filings?ticker=CAI&form=8-K, /gw/filings/facts?ticker=CAI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange